G 
Gansu Longshenrongfa Pharmaceutical Industry Co 300534.SZ · CNY
Health Care · Shenzhen · 🇨🇳 China
10.22
+3.44%
Close of 9 Nov 2026, in CNY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in CNY, from our data supplier.
Revenue
CN¥887.0m
FY2016FY2025
Net income
CN¥44.0m
FY2016FY2025
Free cash flow
−CN¥49.9m
FY2016FY2025
Shareholders' equity
CN¥708.5m
FY2016FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | CN¥887.0m | CN¥1.04bn | CN¥1.08bn | CN¥799.7m | CN¥287.8m | CN¥254.9m | CN¥239.0m | CN¥203.2m | CN¥269.6m | CN¥269.7m |
| Research and development | CN¥27.2m | CN¥24.1m | CN¥30.2m | CN¥27.1m | CN¥6.7m | CN¥6.0m | CN¥7.4m | CN¥6.7m | CN¥6.1m | CN¥6.4m |
| Operating income | CN¥105.6m | CN¥105.8m | CN¥95.2m | CN¥62.3m | −CN¥9.4m | CN¥5.9m | CN¥19.5m | CN¥13.5m | CN¥18.1m | CN¥50.1m |
| Net income | CN¥44.0m | CN¥25.8m | CN¥61.6m | CN¥38.8m | −CN¥9.1m | CN¥1.8m | CN¥12.8m | CN¥12.3m | CN¥17.1m | CN¥47.3m |
| Diluted earnings per share | 0.14 | 0.09 | 0.20 | 0.13 | -0.03 | 0.01 | 0.04 | 0.04 | 0.06 | 0.16 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | CN¥1.39bn | CN¥1.40bn | CN¥1.34bn | CN¥912.8m | CN¥824.1m | CN¥866.7m | CN¥810.1m | CN¥778.5m | CN¥782.2m | CN¥763.5m |
| Cash and short-term investments | — | CN¥289.7m | CN¥288.9m | CN¥97.8m | CN¥99.1m | CN¥118.2m | CN¥51.6m | CN¥63.0m | CN¥58.6m | CN¥124.3m |
| Total liabilities | CN¥613.4m | CN¥674.4m | CN¥625.1m | CN¥149.7m | CN¥91.2m | CN¥127.5m | CN¥71.3m | CN¥57.7m | CN¥70.0m | CN¥59.7m |
| Debt | CN¥103.3m | CN¥98.4m | CN¥143.3m | — | — | CN¥70.1m | CN¥24.0m | CN¥10.0m | CN¥10.0m | CN¥2.2m |
| Shareholders' equity | CN¥708.5m | CN¥662.3m | CN¥633.7m | CN¥746.1m | CN¥720.3m | CN¥729.4m | CN¥730.6m | CN¥720.8m | CN¥712.2m | CN¥703.7m |
| Shares outstanding | 304m | 302m | 304m | 303m | 305m | 312m | 302m | 303m | 304m | 303m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | −CN¥6.5m | CN¥170.1m | CN¥96.5m | CN¥11.4m | CN¥51.1m | CN¥43.5m | CN¥28.2m | CN¥10.2m | −CN¥2.1m | CN¥13.1m |
| Capital spending | −CN¥43.4m | −CN¥78.2m | −CN¥126.4m | −CN¥13.6m | −CN¥413,699 | −CN¥18.6m | −CN¥28.5m | −CN¥2.8m | −CN¥55.7m | −CN¥53.0m |
| Free cash flow | −CN¥49.9m | CN¥91.9m | −CN¥29.8m | −CN¥2.2m | CN¥50.7m | CN¥24.9m | −CN¥314,832 | CN¥7.5m | −CN¥57.8m | −CN¥39.9m |
| Dividends paid | −CN¥14.8m | −CN¥15.3m | −CN¥3.8m | −CN¥494,972 | −CN¥534,967 | −CN¥3.0m | −CN¥3.0m | −CN¥4.0m | −CN¥8.7m | −CN¥7.3m |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | CN¥100.8m | CN¥231.6m | CN¥254.8m | CN¥151.1m | CN¥206.8m | CN¥289.4m | CN¥232.9m | CN¥231.1m |
| Operating income | CN¥1.5m | CN¥38.2m | CN¥42.5m | CN¥4.2m | CN¥12.8m | CN¥45.3m | CN¥32.8m | CN¥14.8m |
| Net income | −CN¥11.0m | CN¥24.7m | CN¥21.6m | −CN¥926,726 | CN¥3.7m | CN¥24.2m | CN¥1.0m | CN¥3.1m |
| Diluted earnings per share | -0.04 | 0.08 | 0.07 | -0.00 | 0.01 | 0.08 | 0.00 | 0.01 |
| Cash from operations | — | — | — | −CN¥17.0m | −CN¥30.0m | −CN¥32.0m | CN¥5.0m | CN¥1.0m |
| Capital spending | −CN¥9.0m | −CN¥10.0m | −CN¥3.0m | −CN¥8.0m | −CN¥23.0m | −CN¥8.0m | −CN¥24.0m | −CN¥19.0m |
| Free cash flow | — | — | — | −CN¥25.0m | −CN¥53.0m | −CN¥40.0m | −CN¥19.0m | −CN¥18.0m |
| Total assets | CN¥1.32bn | CN¥1.42bn | CN¥1.39bn | CN¥1.32bn | CN¥1.38bn | CN¥1.43bn | CN¥1.40bn | CN¥1.37bn |
| Cash and short-term investments | — | — | — | CN¥178.6m | CN¥215.2m | CN¥274.8m | CN¥289.7m | CN¥315.7m |
| Debt | CN¥103.3m | CN¥103.3m | CN¥103.3m | CN¥7.4m | CN¥124.1m | CN¥98.4m | CN¥95.8m | CN¥103.8m |
| Shareholders' equity | CN¥716.1m | CN¥733.1m | CN¥708.5m | CN¥690.1m | CN¥697.5m | CN¥699.8m | CN¥662.3m | CN¥646.3m |
Financial ratios
Data as of 24 Oct 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | |
|---|---|---|---|---|---|---|---|---|
| Operating margin | 9.4% | 10.3% | 9.4% | 8.3% | -1.5% | 2.3% | — | — |
| Net margin | 5.0% | 2.5% | 5.7% | 4.9% | -3.2% | 0.7% | — | — |
| Return on equity | 6.2% | 3.9% | 9.7% | 5.2% | -1.3% | 0.3% | — | — |
| Return on assets | 3.2% | 1.8% | 4.6% | 4.2% | -1.1% | 0.2% | — | — |
| Free cash flow yield | 1.2% | 8.0% | 7.2% | 0.8% | 1.7% | 1.9% | — | — |
| Revenue growth | -14.6% | -3.8% | 35.1% | 177.8% | 12.9% | 6.7% | — | — |
| Earnings growth | 70.3% | -58.1% | 58.9% | -525.9% | -597.3% | -85.7% | — | — |
| Current ratio | 1.43x | 1.30x | 1.33x | 3.16x | 4.52x | 3.22x | — | — |
| Debt to equity | 0.15x | 0.14x | 0.22x | — | — | 0.10x | 0.03x | 0.01x |
| Equity ratio | 50.8% | 47.2% | 47.4% | 81.7% | 87.4% | 84.2% | — | — |
| Interest coverage | 31.47x | 32.30x | 24.88x | 2222.12x | -7.49x | 2.80x | — | — |
| R&D as a share of sales | 3.1% | 2.3% | 2.8% | 3.4% | 2.3% | 2.3% | — | — |
| Buybacks as a share of market value | -0.4% | 0.4% | -0.3% | 0.6% | 2.2% | -3.3% | — | — |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 3.5% | 28.3% | 12.3% |
| Operating income | 19.2% | 77.8% | 4.2% |
| Net income | 4.3% | 88.8% | -3.2% |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Operating margin | 11.0% | 9.7% | 8.4% | 9.6% |
| Net margin | 3.6% | 4.5% | 3.7% | 5.6% |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings | 65.4 | 101.9 | 48.6 | 69.2 | -492.2 | — | 140.5 | 141.3 | 177.5 | 117.0 |
| Price to sales | 3.2 | 2.5 | 2.8 | 3.4 | 15.6 | 7.1 | 7.5 | 8.5 | 11.3 | 20.5 |
Dividends and splits
Per share, in the currency the company pays
Paid for 2 years. Last went ex-dividend on 22 May 2026.
| FY2026 | FY2025 | FY2024 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|
| Paid in the year | 0.02 | 0.04 | 0.04 | 0.01 | 0.01 | 0.012 | 0.029 |
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.